4886 — ASKA Pharmaceutical Holdings Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥64bn
- ¥54bn
- ¥60bn
- 66
- 62
- 98
- 92
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Tanshin | Yuho | Yuho |
Standards: | JAS | JAS | — | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,883 | 901 | 3,575 | 6,163 | 5,357 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -549 | 298 | -210 | -2,485 | -387 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,651 | -5,453 | -187 | -3,721 | -4,747 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2,504 | -493 | 6,540 | 2,842 | 3,350 |
Capital Expenditures | -15,723 | -2,264 | -1,104 | -2,377 | -746 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 943 | -663 | -1,762 | 9,120 | -380 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -14,780 | -2,927 | -2,866 | 6,743 | -1,126 |
Financing Cash Flow Items | -90 | — | — | -2 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 13,036 | -392 | -455 | -2,996 | -1,820 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 760 | -3,812 | 3,219 | 6,589 | 402 |